Publication charges for this article were waived due to the ongoing pandemic of COVID-19.
Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, de Visser M, 2014. Rhabdomyolysis: review of the literature. Neuromuscul Disord 24: 651–659.
Guis S, Mattei JP, Cozzone PJ, Bendahan D, 2005. Pathophysiology and clinical presentations of rhabdomyolysis. Joint Bone Spine 72: 382–391.
Wen Z, Liang Y, Hao Y, Delavan B, Huang R, Mikailov M, Tong W, Li M,, Liu Z, 2019. Drug-induced rhabdomyolysis atlas (DIRA) for idiosyncratic adverse drug reaction management. Drug Discov Today 24: 9–15.
Feng Y et al. 2020. COVID-19 with different severity: a multi-center study of clinical features. Am J Respir Crit Care Med 201: 1380–1388.
Rodriguez-Morales AJ et al. 2020. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 34: 101623.
Wang D et al. 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323: 1061–1069.
Turkish Ministry of Health, 2020. COVID-19 (SARS-CoV-2 Infection) Guideline, April 13, 2020. Ankara, Turkey: Turkish Ministry of Health. Available at: https://covid19bilgi.saglik.gov.tr/tr/covid-19-rehberi.html.
Li R-L, Chu S-G, Luo Y, Huang Z-H, Hao Y, Fan C-H, 2020. Atypical presentation of SARS-CoV-2 infection: a case report. World J Clin Cases 8: 1265.
Fadila MF, Wool KJ, 2015. Rhabdomyolysis secondary to influenza a infection: a case report and review of the literature. N Am J Med Sci 7: 122–124.
Jin M, Tong Q, 2020. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis 26: [Epub ahead of print].